News & Perspective

Sep 20, 2002

Sep 20, 2002

Acambis says its smallpox vaccine worked well in second trial

(CIDRAP News) – The smallpox vaccine being produced by Acambis plc for the US government worked well in its second trial, generating a characteristic vaccinia lesion in all recipients and causing no serious adverse events, the company said this week.

Sep 05, 2002

Sep 05, 2002

Acambis reports successful phase I trial of cell-culture-grown smallpox vaccine

(CIDRAP News) Ð The smallpox vaccine being produced by Acambis plc for the US government as part of the nation's bioterrorism preparedness program worked well in a Phase I trial, Acambis officials announced this week.

The vaccine, called ACAM1000, generated a characteristic skin lesion or "take" in all those vaccinated, and there were no serious or unusual side effects, the company reported in a Sep 3 news release.

Sep 04, 2002

Sep 04, 2002

Smallpox vaccination decision in White House hands

(CIDRAP News) – The Department of Health and Human Services (HHS) recently sent a recommendation on smallpox vaccination policy to President Bush, but HHS officials still are not confirming reports that it calls for vaccinating as many as 500,000 healthcare workers.

"I can't confirm anything other than that the recommendation went to the White House," Bill Pierce, an HHS spokesman in Washington, DC, told CIDRAP News today.